Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients-Reference-Cited by-同舟云学术

Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients

Published:2022-10-26 Issue:11 Volume:10 Page:
ISSN:2050-4527
Container-title:Immunity, Inflammation and Disease
language:en
Short-container-title:Immunity Inflam & Disease

Author:

de Graaf Dennis M.¹²^ORCID,Teufel Lisa U.¹,de Nooijer Aline H.¹,van Gammeren Adriaan J.³,Ermens Antonius A. M.³,Gaál Ildikó O.⁴,Crișan Tania O.⁴,van de Veerdonk Frank L.¹,Netea Mihai G.¹⁵,Dinarello Charles A.¹²,Joosten Leo A. B.¹⁴,Arts Rob J. W.¹,

Affiliation:

1. Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboudumc Center for Infectious Diseases Radboud University Medical Center Nijmegen The Netherlands

2. Department of Medicine University of Colorado Aurora Colorado USA

3. Department of Clinical Chemistry and Hematology Amphia Hospital Breda The Netherlands

4. Department of Medical Genetics Iuliu Hatieganu University of Medicine and Pharmacy Cluj‐Napoca Romania

5. Department of Immunology and Metabolism, Life and Medical Sciences Institute University of Bonn Bonn Germany

Funder

European Research Council

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.712

Reference67 articles.

1. World Health Organization (WHO). Weekly operational update on COVID‐19. December 21 2021. Accessed February 11 2022.https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19---21-december-2021

2. An inflammatory cytokine signature predicts COVID-19 severity and survival

3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

4. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19

5. Targeting of the NLRP3 inflammasome for early COVID‐19;Marchetti C;bioRxiv,2021